Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

Abstract

This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes. This therapeutic agent may be able to be used on a once-every-month or longer schedule.

References

Page 1

	Year	Citations
Diagnosis and Classification of Diabetes Mellitus Diabetes Care	2010	14K
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Masafumi Matsuda, Ralph A. DeFronzo Diabetes Care	1999	5.5K
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Bolormaa Vandanmagsar, Yun‐Hee Youm, Anthony Ravussin, Nature Medicine ObesityMetabolic SyndromeInflammationInsulin ResistanceDiabetes	2011	2.5K
Interleukin-1–Receptor Antagonist in Type 2 Diabetes Mellitus Claus M. Larsen, Mirjam Faulenbach, Allan Vaag, New England Journal of Medicine	2007	1.8K
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling Haitao Wen, Denis Gris, Yu L. Lei, Nature Immunology InflammationMetabolic SyndromeDiabetesImmunologyMetabolic Regulation	2011	1.7K
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets Kathrin Maedler, Frédéric Ris, José Oberholzer, Journal of Clinical Investigation ImmunologyImmune RegulationCell DeathInsulin SignalingIl-1β Contributes	2002	979
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells Helga Ellingsgaard, Irina Häuselmann, Beat Schuler, Nature Medicine InflammationL CellsMolecular PhysiologyPhysiologyImmunology	2011	897
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Paul M. Ridker, Tom Thurén, Andrew Zalewski, American Heart Journal	2011	785
Increased Number of Islet-Associated Macrophages in Type 2 Diabetes Jan A. Ehses, Aurel Perren, Elisabeth Eppler, Diabetes	2007	770
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity Rinke Stienstra, Leo A. B. Joosten, Tim B. Koenen, Cell Metabolism ObesityMetabolic SyndromeInflammationInsulin SensitivitySignal Transduction	2010	644

Page 1